Related Experiment Video
Updated: Jan 23, 2026

04:11
Endolymphatic Duct Blockage as a Surgical Treatment Option for Ménière's Disease
Published on: April 28, 2023
2.5K
[Cancer treatment; there are options]
Liesbeth J Boersma1,2, Gabe S Sonke3, Helena M Verkooijen4
1Maastricht UMC+, afd. Radiotherapie (MAASTRO), GROW School for Oncology and Developmental Biology, Maastricht.
Nederlands Tijdschrift Voor Geneeskunde
|June 13, 2019
Summary
Cancer treatment de-escalation strategies are crucial for long-term survivors but lack robust evidence. Physicians must use shared decision-making and collect data while addressing barriers to future randomized studies.
Area of Science:
- Oncology
- Clinical Research
- Patient Care
Background:
- Increasing long-term cancer survival necessitates focus on preventing late treatment effects.
- Treatment de-escalation strategies are emerging as a key approach for mitigating adverse outcomes.
- Randomized studies on de-escalation strategies are often not feasible, creating an evidence gap.
Purpose of the Study:
- To highlight the importance of treatment de-escalation in long-term cancer survivorship.
- To outline the responsibilities of physicians in the absence of definitive evidence for de-escalation.
- To identify barriers hindering future randomized studies on cancer treatment de-escalation.
Main Methods:
- Discussion of physician responsibilities including shared decision-making and data collection.
- Analysis of challenges in conducting randomized studies for treatment de-escalation.
- Emphasis on the need for improved data and organizational structures to support evidence-based practice.
Main Results:
- Physicians share responsibility for applying shared decision-making and collecting outcome data.
- Lack of robust evidence for de-escalation strategies necessitates careful patient-physician communication.
- Barriers to randomized studies must be overcome to establish definitive evidence for de-escalation.
Conclusions:
- Physicians must actively engage in shared decision-making and data collection for cancer treatment de-escalation.
- Overcoming barriers is essential for conducting future randomized studies on de-escalation strategies.
- Organizing cancer care to facilitate learning from all patients will strengthen future decision-making.
Related Concept Videos
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Parkinson's Disease: Treatment
1.0K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.0K
Alzheimer's Disease: Treatment
845
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
845
Open Angle Glaucoma: Treatment
969
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
969
Cancer
53.8K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.8K
What is Cancer?
14.1K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
14.1K

